This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Mary M Chen
Introduction
Mary M Chen is a prominent inventor based in Hoboken, NJ (US). She has made significant strides in the field of pharmaceuticals, particularly in the treatment of sarcomas. Her work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Mary M Chen holds a patent titled "Radioconjugates Targeting CD33 in the Treatment of Sarcomas." This patent reflects her dedication to developing targeted therapies that can improve patient outcomes in oncology. She has 1 patent to her name, showcasing her contributions to the field.
Career Highlights
Mary is currently employed at Actinium Pharmaceuticals, Limited, where she continues to push the boundaries of medical research. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking projects.
Collaborations
Throughout her career, Mary has worked alongside notable colleagues such as Avinash Desai and Dale Lincoln Ludwig. These collaborations have enriched her research and expanded the impact of her work in the pharmaceutical industry.
Conclusion
Mary M Chen exemplifies the spirit of innovation in the medical field. Her contributions, particularly in the development of targeted therapies, highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile